See more : New Tripoli Bancorp, Inc. (NTBP) Income Statement Analysis – Financial Results
Complete financial analysis of Creative Medical Technology Holdings, Inc. (CELZ) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Creative Medical Technology Holdings, Inc., a leading company in the Biotechnology industry within the Healthcare sector.
You may be interested
- HTG Molecular Diagnostics, Inc. (HTGM) Income Statement Analysis – Financial Results
- Shenzhen Deren Electronic Co., Ltd. (002055.SZ) Income Statement Analysis – Financial Results
- Biomotion Sciences Warrant (SLXNW) Income Statement Analysis – Financial Results
- British & American Investment Trust PLC (BAF.L) Income Statement Analysis – Financial Results
- V-TAC Technology Co.,Ltd. (6229.TWO) Income Statement Analysis – Financial Results
Creative Medical Technology Holdings, Inc. (CELZ)
About Creative Medical Technology Holdings, Inc.
Creative Medical Technology Holdings, Inc., a biotechnology company, focuses on immunology, urology, orthopedics, and neurology using adult stem cell treatments. The company offers CaverStem to treat erectile dysfunction; FemCelz for the treatment of loss of genital sensitivity and dryness; StemSpine to treat chronic lower back pain; ImmCelz for the treatment of stroke patients; and OvaStem for treatment of female infertility. Creative Medical Technology Holdings, Inc. is based in Phoenix, Arizona.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 9.00K | 88.60K | 87.75K | 164.50K | 165.50K | 124.40K | 4.80K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 3.60K | 28.49K | 47.95K | 50.60K | 45.50K | 70.38K | 8.00K | 766.07K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 5.40K | 60.11K | 39.81K | 113.90K | 120.00K | 54.03K | -3.20K | -766.07K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit Ratio | 60.00% | 67.84% | 45.36% | 69.24% | 72.51% | 43.43% | -66.67% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 1.97M | 6.27M | 109.18K | 0.00 | 0.00 | 96.62K | 260.09K | 85.33K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 1.22M | 1.05M | 898.53K | 664.98K | 20.83K | 19.43K | 20.12K | 20.10K | 0.00 | 14.29K | 30.55K | 53.49K | 13.62K | 1.43K |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 3.56M | 3.94M | 2.96M | 1.16M | 1.22M | 1.05M | 898.53K | 664.98K | 20.83K | 19.43K | 20.12K | 20.10K | 19.83K | 14.29K | 30.55K | 53.49K | 13.62K | 1.43K |
| Other Expenses | 94.58K | 92.08K | 92.08K | 66.79K | 26.95K | 21.14K | 0.00 | 9.36K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 5.53M | 10.30M | 3.17M | 1.23M | 1.25M | 1.17M | 1.17M | 759.67K | 20.83K | 19.43K | 20.12K | 20.10K | 19.83K | 14.29K | 30.55K | 53.49K | 13.62K | 1.43K |
| Cost & Expenses | 5.63M | 10.33M | 3.21M | 1.28M | 1.30M | 1.24M | 1.18M | 759.67K | 20.83K | 19.43K | 20.12K | 20.10K | 19.83K | 14.29K | 30.55K | 53.49K | 13.62K | 1.43K |
| Interest Income | 333.56K | 100.33K | 4.28M | 1.23M | 1.90M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 469.00 | 2.33K | 1.95K |
| Interest Expense | 0.00 | 0.00 | 4.28M | 1.23M | 1.90M | 1.36M | 377.59K | 6.40K | 9.93K | 8.59K | 7.16K | 5.49K | 4.23K | 2.97K | 1.06K | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 94.58K | 92.08K | 92.08K | 66.79K | 26.95K | 21.14K | 15.99K | 9.36K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EBITDA | -5.53M | -10.15M | -3.03M | -1.05M | -1.10M | -1.09M | -1.16M | -750.32K | -20.83K | -19.43K | -20.12K | -20.10K | -19.83K | -14.29K | -30.55K | -53.49K | -13.62K | -1.43K |
| EBITDA Ratio | -61,394.98% | -11,345.33% | -3,457.24% | -637.11% | -666.60% | -878.68% | -24,204.40% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | -5.62M | -10.24M | -3.13M | -1.11M | -1.13M | -1.11M | -1.18M | -766.07K | -20.83K | -19.43K | -20.12K | -20.10K | -19.83K | -14.29K | -30.55K | -53.49K | -13.62K | -1.43K |
| Operating Income Ratio | -62,445.91% | -11,562.50% | -3,562.17% | -677.71% | -682.88% | -895.68% | -24,537.63% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | 333.56K | 100.33K | 22.34M | -35.21M | -7.35M | -12.54M | -1.48M | -6.40K | -9.93K | -8.59K | -7.16K | -5.49K | -4.23K | -2.97K | -1.06K | 2.22K | 2.33K | 1.95K |
| Income Before Tax | -5.29M | -10.14M | 19.21M | -36.33M | -8.48M | -13.66M | -2.66M | -766.07K | -30.76K | -28.01K | -27.28K | -25.59K | -24.06K | -17.26K | -31.61K | -51.27K | -11.29K | 523.00 |
| Income Before Tax Ratio | -58,739.71% | -11,449.26% | 21,892.75% | -22,082.21% | -5,126.09% | -10,977.21% | -55,398.08% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 0.00 | -100.33K | 4.28M | 1.23M | 1.90M | -11.18M | 377.59K | 12.80K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.36K | -661.00 | 162.00 |
| Net Income | -5.29M | -10.04M | 14.93M | -37.55M | -10.38M | -13.66M | -2.66M | -766.07K | -30.76K | -28.01K | -27.28K | -25.59K | -24.06K | -17.26K | -31.61K | -52.64K | -9.54K | 1.37K |
| Net Income Ratio | -58,739.71% | -11,336.02% | 17,017.27% | -22,829.68% | -6,271.42% | -10,977.21% | -55,398.08% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | -3.76 | -9.19 | 57.32 | -648.10 | -5.02K | -11.35K | -17.38K | -5.47K | -1.28K | -1.17K | -1.14K | -1.07K | -1.00K | -719.00 | -1.32K | -2.19K | -397.67 | 57.17 |
| EPS Diluted | -3.76 | -9.19 | 45.97 | -648.10 | -5.02K | -11.35K | -17.38K | -5.47K | -1.28K | -1.17K | -1.14K | -1.07K | -1.00K | -719.00 | -1.32K | -2.19K | -397.67 | 57.17 |
| Weighted Avg Shares Out | 1.41M | 1.09M | 260.51K | 57.95K | 2.07K | 1.20K | 153.00 | 140.00 | 24.00 | 24.00 | 24.00 | 24.00 | 24.00 | 24.00 | 24.00 | 24.00 | 24.00 | 24.00 |
| Weighted Avg Shares Out (Dil) | 1.41M | 1.09M | 324.86K | 57.95K | 2.07K | 1.20K | 153.00 | 140.00 | 24.00 | 24.00 | 24.00 | 24.00 | 24.00 | 24.00 | 24.00 | 24.00 | 24.00 | 24.00 |
Why Is Creative Medical Technology (CELZ) Stock Up Today?
Creative Medical Technology announced positive results concerning its StemSpine procedure. Here's what you should know as CELZ stock rises.
Why Creative Medical Technology Shares Are Soaring
Creative Medical Technology Holdings Inc (NASDAQ: CELZ) shares are trading higher Wednesday after the company announced top-line results for its follow-up StemSpine pilot study. The initial study showed significant efficacy of the StemSpine procedure for treating chronic lower back.
Creative Medical Shares Soar On Positive Data from StemSpine Pilot Study
Creative Medical Technology Holdings (NASDAQ: CELZ) has announced positive two-year follow-up data from its StemSpine pilot study.
Trading Penny Stocks? Top Stock Market News For March 23rd, 2022
Here's what you need to know about trading penny stocks on March 23rd The post Trading Penny Stocks? Top Stock Market News For March 23rd, 2022 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Best Penny Stocks To Buy? 8 Low Float Stocks To Watch Right Now
Low float penny stocks to add to your watch list right now. The post Best Penny Stocks To Buy?
Trading Penny Stocks? Top Stock Market News for February 18th, 2022
Here's what you need to know about trading penny stocks today The post Trading Penny Stocks? Top Stock Market News for February 18th, 2022 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
4 Low Float Penny Stocks To Watch After ISPO Stock Explodes
Low float penny stocks to watch right now. The post 4 Low Float Penny Stocks To Watch After ISPO Stock Explodes appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
4 Top Penny Stocks To Watch For A Short Squeeze
Short squeeze penny stocks to watch The post 4 Top Penny Stocks To Watch For A Short Squeeze appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
7 Short Squeeze Penny Stocks To Buy For Under $5 Right Now
Short squeeze penny stocks to watch right now. The post 7 Short Squeeze Penny Stocks To Buy For Under $5 Right Now appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Short Squeeze Penny Stocks To Buy Now? 4 To Watch Under $5
Will these penny stocks see a short squeeze this week? The post Short Squeeze Penny Stocks To Buy Now?
Source: https://incomestatements.info
Category: Stock Reports